Product Program year 2025 Source: CMS Open Payments

Bioprotect Balloon Implant System

Device Rectal Spacers Used in Prostate Cancer Radiation Therapy

PDI 07290014878020

Open in the dashboard

General payments

$916,103

3,395 payments

Research payments

$58,208

8 payments

Through program year 2025, $916,103 in general payments and $58,208 in research payments were reported against Bioprotect Balloon Implant System (Rectal Spacers Used in Prostate Cancer Radiation Therapy).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $767,568 2,438
2025 Research $58,208 8
2024 General $148,535 957

Breakdown

Who paid General payments · program years 2024–2025
  1. Bioprotect Medical, Inc. $894,503 3,391 payments
  2. Bioprotect Ltd. $21,600 4 payments
Top recipients General payments · program year 2025
  1. Shawn Zimberg Radiation Oncology · Plainview, NY $248,371 32% · 50 payments
  2. Daniel Kim Radiation Oncology · Fairfax, VA $62,426 8% · 131 payments
  3. Dean Laganosky Urology · Plymouth Meeting, PA $55,397 7% · 39 payments
  4. Jeffrey Wolters Urology · Pensacola, FL $32,821 4% · 23 payments
  5. Paulas Vyas Urology · Safety Harbor, FL $30,831 4% · 23 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Radiation Oncology Radiology $546,736 71% · 296 practitioners
  2. Urology $199,240 26% · 571 practitioners
  3. Physician Assistant $4,324 <1% · 108 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $3,557 <1% · 81 practitioners
  5. Nurse Practitioner $1,938 <1% · 44 practitioners

The top 5 of 43 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $301,885 39% · 30 recipients
  2. Florida $84,802 11% · 197 recipients
  3. Virginia $71,772 9% · 61 recipients
  4. Pennsylvania $61,202 8% · 86 recipients
  5. Texas $46,294 6% · 86 recipients

The top 5 of 42 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

3,395 general · 8 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record